Your browser doesn't support javascript.
loading
Vorinostat in patients with resistant BRAFV600E mutated advanced melanoma: a proof of concept study.
Huijberts, Sanne; Wang, Liqin; de Oliveira, Rodrigo Leite; Rosing, Hilde; Nuijen, Bastiaan; Beijnen, Jos; Bernards, Rene; Schellens, Jan; Wilgenhof, Sofie.
Afiliação
  • Huijberts S; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands.
  • Wang L; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands.
  • de Oliveira RL; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands.
  • Rosing H; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands.
  • Nuijen B; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands.
  • Beijnen J; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands.
  • Bernards R; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands.
  • Schellens J; Faculty of Science, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands.
  • Wilgenhof S; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands.
Future Oncol ; 16(11): 619-629, 2020 Apr.
Article em En | MEDLINE | ID: mdl-32125175

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas B-raf / Inibidores de Histona Desacetilases / Vorinostat / Melanoma Limite: Humans Idioma: En Revista: Future Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas B-raf / Inibidores de Histona Desacetilases / Vorinostat / Melanoma Limite: Humans Idioma: En Revista: Future Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda